[ET Net News Agency, 24 July 2025] AKESO (09926) rose 7.2% to HK$153.7.
It hits an intra-day high of HK$153.8, hitting a historical high, and an intra-day low of HK$145.3. The total shares traded was 9.49 million, with a value of HK$1.42b. The active buy/sell ratio is 67:33, with net buying turnover of HK$451.84m. BNP PARIBAS SEC (ASIA) accounts for greatest net responsive buying turnover of HK$11.19m, with volume weighted average price of HK$149.441. CHINA INNOVATION MARKET SER accounts for greatest net responsive selling turnover of HK$89.14m, with volume weighted average price of HK$150.051.
Basic Information| Nominal | 153.700 | % Chg | +7.18% |
| High | 153.800 | Low | 145.300 |
| Shares Tr | 9.49m | Turnover | 1.42b |
| 10-D SMA | 134.300 | %H.V | 73.428 |
| 20-D SMA | 118.910 | VWAP | 149.574 |
| 50-D SMA | 100.349 | RSI14 | 81.276 |
Status: Hitting a historical high, active buy/sell ratio is 67:33, with net buying turnover of HK$451.84m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| AKESO (09926) | 153.70 | +7.18 |
| SINO BIOPHARM (01177) | 6.75 | +0.90 |
| 3SBIO (01530) | 30.65 | +7.36 |
| EVEREST MED (01952) | 76.15 | +7.71 |
| KEYMED BIO-B (02162) | 61.65 | +6.29 |
| WUXI XDC (02268) | 57.45 | +7.08 |
| ASCENTAGE-B (06855) | 76.35 | +3.60 |
| SKB BIO-B (06990) | 384.60 | +2.56 |
| ZAI LAB (09688) | 29.75 | +1.02 |
| REMEGEN (09995) | 67.85 | +2.03 |
(ed)
